VENETIS, KONSTANTINOS
VENETIS, KONSTANTINOS
Dipartimento di Oncologia ed Emato-Oncologia
Mismatch repair (MMR) and microsatellite instability (MSI) phenotypes across solid tumors: A comprehensive cBioPortal study on prevalence and prognostic impact
2025 K. Venetis, C. Frascarelli, L.B. Bielo, G. Cursano, R. Adorisio, M. Ivanova, E. Mane, V. Peruzzo, A. Concardi, M. Negrelli, M. D'Ercole, F.M. Porta, Y. Zhan, A. Marra, D. Trapani, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, N. Fusco
Next-generation sequencing methodologies to identify patients for targeted therapy: focus on HR+/HER2- metastatic breast cancer
2025 U. Malapelle, S. Buglioni, I. Castellano, C. Criscitiello, G. Curigliano, G. D'Amati, C. De Angelis, D. De Biase, F. Pepe, G. Perrone, C. Scatena, M. Scatolini, D. Trapani, K. Venetis, N. Fusco
Artificial Intelligence in Thyroid Cytopathology: Diagnostic and Technical Insights
2025 M. Negrelli, C. Frascarelli, F. Maffini, E. Mangione, C. Di Tonno, M. Lombardi, F.M. Porta, M. Urso, V. L'Imperio, F. Pagni, C. Bellevicine, M. Nacchio, U. Malapelle, G. Troncone, A. Marra, G. Curigliano, K. Venetis, E. Guerini-Rocco, N. Fusco
Inter-Assay Variability of TROP2 Immunohistochemistry in Triple-Negative Breast Cancer
2025 G. Cursano, A. Concardi, M. Ivanova, C. Frascarelli, E. Mane, E. Mangione, S. Santaguida, D. Tosoni, S. Pece, A. Marra, C. Criscitiello, G. Curigliano, G. Viale, K. Venetis, E.G. Rocco, N. Fusco
PIK3CA testing in HR+/HER2- metastatic breast cancer: assessing pathology laboratories capacity and needs
2025 E. Mane, G. Cursano, K. Venetis, C. Frascarelli, F. Pepe, M. Nacchio, L. Palumbo, P. Pisapia, E. De Camilli, I. Castellano, B. Cerbelli, L. Costarelli, G. D'Amati, A. Rizzo, A. Santinelli, C. Scatena, C. Criscitiello, C. De Angelis, M.V. Dieci, G. Troncone, G. Curigliano, G. Viale, E. Guerini-Rocco, U. Malapelle, N. Fusco
Computational pathology in breast cancer: optimizing molecular prediction through task-oriented AI models
2025 C. Frascarelli, K. Venetis, A. Marra, A. Concardi, M. D'Ercole, E. Mangione, M. Negrelli, F.M. Porta, S. Keswani, G. Curigliano, E. Guerini-Rocco, N. Fusco
ADT with SBRT versus SBRT alone for hormone-sensitive oligorecurrent prostate cancer (RADIOSA): a randomised, open-label, phase 2 clinical trial
2025 G. Marvaso, G. Corrao, M. Zaffaroni, M.G. Vincini, C. Lorubbio, S. Gandini, C. Fodor, S. Netti, D. Zerini, S. Luzzago, F.A. Mistretta, K. Venetis, G. Cursano, T. Burla, K. Mazzocco, F. Cattani, G. Petralia, N. Fusco, G. Pravettoni, G. Musi, O. De Cobelli, C. Tang, P. Ost, D.A. Palma, R. Orecchia, B.A. Jereczek-Fossa
Investigating the Pathogenicity of Uncommon KRAS Mutations and Their Association with Clinicopathologic Characteristics in Patients with Colorectal Cancer
2025 R. Adorisio, D. Ciardiello, A. Rappa, L. Gervaso, G. Pelizzari, L. Marinucci, N. Fusco, M.G. Zampino, N. Fazio, K. Venetis, E. Guerini-Rocco
ESR1 testing on FFPE samples from metastatic lesions in HR + /HER2- breast cancer after progression on CDK4/6 inhibitor therapy
2025 K. Venetis, G. Cursano, R. Scafetta, P.P.M.B. Giachetti, A. Concardi, E. De Camilli, M. D'Ercole, E. Mane, C. Frascarelli, A. Marra, S. Gandini, F. Pepe, S. Scagnoli, S.M. Rossi, R. Troiano, E. Speziale, C. De Angelis, G. Troncone, U. Malapelle, G. Perrone, A. Botticelli, G. Viale, G. Curigliano, E. Guerini Rocco, C. Criscitiello, N. Fusco
Non-Small Cell Lung Cancer Testing on Reference Specimens: An Italian Multicenter Experience
2024 F. Pepe, G. Russo, A. Venuta, C. Scimone, M. Nacchio, P. Pisapia, G. Goteri, F. Barbisan, C. Chiappetta, A. Pernazza, D. Campagna, M. Giordano, G. Perrone, G. Sabarese, A. Altimari, D. De Biase, G. Tallini, D. Calistri, E. Chiadini, L. Capelli, A. Santinelli, A.E. Gulini, E. Pierpaoli, M. Badiali, S. Murru, R. Murgia, E. Guerini Rocco, K. Venetis, N. Fusco, D. Morotti, A. Gianatti, D. Furlan, G. Rossi, L. Melocchi, M. Russo, C. De Luca, L. Palumbo, S. Simonelli, A. Maffè, P. Francia Di Celle, T. Venesio, M. Scatolini, E. Grosso, S. Orecchia, M. Fassan, M. Balistreri, E. Zulato, D. Reghellin, E. Lazzari, M. Santacatterina, M.L. Piredda, M. Riccardi, L. Laurino, E. Roz, D. Longo, D.P. Romeo, C. Fazzari, A. Moreno-Manuel, G.D. Puglia, A.D. Prjibelski, D. Shafranskaya, L. Righi, A. Listì, D. Vitale, A. Iaccarino, U. Malapelle, G. Troncone
Early Breast Cancer Risk Assessment: Integrating Histopathology with Artificial Intelligence
2024 M. Ivanova, C. Pescia, D. Trapani, K. Venetis, C. Frascarelli, E. Mane, G. Cursano, E. Sajjadi, C. Scatena, B. Cerbelli, G. D'Amati, F.M. Porta, E. Guerini-Rocco, C. Criscitiello, G. Curigliano, N. Fusco
Standardized pathology report for HER2 testing in compliance with 2023 ASCO/CAP updates and 2023 ESMO consensus statements on HER2-low breast cancer
2024 M. Ivanova, F.M. Porta, M. D'Ercole, C. Pescia, E. Sajjadi, G. Cursano, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, E. Guerini-Rocco, G. Curigliano, G. Viale, N. Fusco
PD-L1 testing in metastatic triple-negative breast cancer: Interobserver and interplatform reproducibility of CE-IVD assays for CPS and IC scores
2024 M. Ivanova, C. Frascarelli, B. Cerbelli, M.G. Pignataro, A. Pernazza, K. Venetis, E. Sajjadi, C. Criscitiello, G. Curigliano, E. Guerini-Rocco, P. Graziano, M. Martini, G. D'Amati, N. Fusco
Standardized molecular pathology workflow for ctDNA-based ESR1 testing in HR+/HER2- metastatic breast cancer
2024 E. Guerini-Rocco, K. Venetis, G. Cursano, E. Mane, C. Frascarelli, F. Pepe, M. Negrelli, E. Olmeda, D. Vacirca, A. Ranghiero, D. Trapani, C. Criscitiello, G. Curigliano, C. Rolfo, U. Malapelle, N. Fusco
PIK3CA testing in hormone receptor-positive/HER2-negative metastatic breast cancer: real-world data from Italian molecular pathology laboratories
2024 F. Pepe, K. Venetis, G. Cursano, C. Frascarelli, P. Pisapia, D. Vacirca, C. Scimone, A. Rappa, G. Russo, E. Mane, F. Pagni, I. Castellano, G. Troncone, C.D. Angelis, G. Curigliano, E. Guerini-Rocco, U. Malapelle, N. Fusco
The Evolving Role of Genomic Testing in Early Breast Cancer: Implications for Diagnosis, Prognosis, and Therapy
2024 K. Venetis, C. Pescia, G. Cursano, C. Frascarelli, E. Mane, E. De Camilli, E. Munzone, S. Dellapasqua, C. Criscitiello, G. Curigliano, E. Guerini Rocco, N. Fusco
Genomic and clinical landscape of metastatic hormone receptors-positive breast cancers carrying ESR1 alterations
2024 L. Boscolo Bielo, E. Guerini Rocco, D. Trapani, P. Zagami, B. Taurelli Salimbeni, A. Esposito, C. Belli, E. Crimini, K. Venetis, E. Munzone, N. Fusco, C. Criscitiello, A. Marra, G. Curigliano
Immune Biomarkers in Triple-Negative Breast Cancer: Improving the Predictivity of Current Testing Methods
2023 F.M. Porta, E. Sajjadi, K. Venetis, C. Frascarelli, G. Cursano, E. Guerini-Rocco, N. Fusco, M. Ivanova
Immune microenvironment dynamics in breast cancer during pregnancy: impact of gestational age on tumor-infiltrating lymphocytes and prognosis
2023 E. Sajjadi, K. Venetis, M. Ivanova, M. Noale, C. Blundo, E. Di Loreto, G. Scarfone, S. Ferrero, S. Maggi, P. Veronesi, V.E. Galimberti, G. Viale, F.A. Peccatori, N. Fusco, E. Guerini-Rocco
Pathological identification of HER2-low breast cancer: Tips, tricks, and troubleshooting for the optimal test
2023 E. Sajjadi, E. Guerini-Rocco, E. De Camilli, O. Pala, G. Mazzarol, K. Venetis, M. Ivanova, N. Fusco